What are the risks of future 'pay for delay' settlements between branded and generic manufacturers?
Philip Kouyoumdjian, Cozen O'Connor
Advertisement
Articles by Philip Kouyoumdjian, Cozen O'Connor
Advertisement
Latest Updated Articles
- Supreme Court: reverse payment settlements subject to antitrust scrutiny
Published: August 28th 2013 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Frontier Scientific Solutions, ATSG Partner to Launch Air Network for Temperature-Controlled Pharmaceuticals
2
Pharma Pulse: Amazon Enters Weight-Loss Drug Market, Merck Expands US Manufacturing, and FDA Approves Tezspire for Chronic Sinusitis
3
Pharma Pulse: Telehealth Medication Abortion Requests Surge, FDA Expedites Tzield Review, and New Biopharma Air Network Launches
4
The Hidden Costs of Specialty Drug Access and Patient Loneliness
5
